カテゴリー： 世界, 医療/バイオ, QYResearch

ペット治療の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Pet Therapeutics Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10464）・商品コード：QY22JLX10464
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ペット治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペット治療の世界市場のxxx％を占める「感染症」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「犬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ペット治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペット治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ペット治療のグローバル主要企業には、Elanco、Boehringer Ingelheim GmbH、Ceva Sante Animale、Dechra Pharmaceuticals、Eli Lilly and Company、Merck、Vetoquinol、Zoetisなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ペット治療市場は、種類と用途によって区分されます。世界のペット治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
感染症、皮膚病、整形外科、行動障害、その他

【用途別セグメント】
犬、猫、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ペット治療製品概要
- 種類別市場（感染症、皮膚病、整形外科、行動障害、その他）
- 用途別市場（犬、猫、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のペット治療販売量予測2017-2028
- 世界のペット治療売上予測2017-2028
- ペット治療の地域別販売量
- ペット治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ペット治療販売量
- 主要メーカー別ペット治療売上
- 主要メーカー別ペット治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（感染症、皮膚病、整形外科、行動障害、その他）
- ペット治療の種類別販売量
- ペット治療の種類別売上
- ペット治療の種類別価格
・用途別市場規模（犬、猫、その他）
- ペット治療の用途別販売量
- ペット治療の用途別売上
- ペット治療の用途別価格
・北米市場
- 北米のペット治療市場規模（種類別、用途別）
- 主要国別のペット治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのペット治療市場規模（種類別、用途別）
- 主要国別のペット治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のペット治療市場規模（種類別、用途別）
- 主要国別のペット治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のペット治療市場規模（種類別、用途別）
- 主要国別のペット治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのペット治療市場規模（種類別、用途別）
- 主要国別のペット治療市場規模（トルコ、サウジアラビア）
・企業情報
Elanco、Boehringer Ingelheim GmbH、Ceva Sante Animale、Dechra Pharmaceuticals、Eli Lilly and Company、Merck、Vetoquinol、Zoetis
・産業チェーン及び販売チャネル分析
- ペット治療の産業チェーン分析
- ペット治療の原材料
- ペット治療の生産プロセス
- ペット治療の販売及びマーケティング
- ペット治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ペット治療の産業動向
- ペット治療のマーケットドライバー
- ペット治療の課題
- ペット治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Pet Therapeutics Market
The global Pet Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Infectious Diseases accounting for % of the Pet Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dogs segment is altered to an % CAGR throughout this forecast period.
China Pet Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Pet Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pet Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pet Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pet Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pet Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pet Therapeutics market.
Global Pet Therapeutics Scope and Market Size
Pet Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pet Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Segment by Application
Dogs
Cats
Other
By Company
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Diseases
1.2.3 Dermatological Diseases
1.2.4 Orthopedic Diseases
1.2.5 Behavioral Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pet Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pet Therapeutics Market Perspective (2017-2028)
2.2 Pet Therapeutics Growth Trends by Region
2.2.1 Pet Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pet Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Pet Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Pet Therapeutics Market Dynamics
2.3.1 Pet Therapeutics Industry Trends
2.3.2 Pet Therapeutics Market Drivers
2.3.3 Pet Therapeutics Market Challenges
2.3.4 Pet Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Therapeutics Players by Revenue
3.1.1 Global Top Pet Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Pet Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Pet Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Therapeutics Revenue
3.4 Global Pet Therapeutics Market Concentration Ratio
3.4.1 Global Pet Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Therapeutics Revenue in 2021
3.5 Pet Therapeutics Key Players Head office and Area Served
3.6 Key Players Pet Therapeutics Product Solution and Service
3.7 Date of Enter into Pet Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Therapeutics Breakdown Data by Type
4.1 Global Pet Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Pet Therapeutics Forecasted Market Size by Type (2023-2028)
5 Pet Therapeutics Breakdown Data by Application
5.1 Global Pet Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Pet Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pet Therapeutics Market Size (2017-2028)
6.2 North America Pet Therapeutics Market Size by Type
6.2.1 North America Pet Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Pet Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Pet Therapeutics Market Share by Type (2017-2028)
6.3 North America Pet Therapeutics Market Size by Application
6.3.1 North America Pet Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Pet Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Pet Therapeutics Market Share by Application (2017-2028)
6.4 North America Pet Therapeutics Market Size by Country
6.4.1 North America Pet Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Pet Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pet Therapeutics Market Size (2017-2028)
7.2 Europe Pet Therapeutics Market Size by Type
7.2.1 Europe Pet Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Pet Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Pet Therapeutics Market Share by Type (2017-2028)
7.3 Europe Pet Therapeutics Market Size by Application
7.3.1 Europe Pet Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Pet Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Pet Therapeutics Market Share by Application (2017-2028)
7.4 Europe Pet Therapeutics Market Size by Country
7.4.1 Europe Pet Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Pet Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Pet Therapeutics Market Size by Type
8.2.1 Asia-Pacific Pet Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pet Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pet Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Pet Therapeutics Market Size by Application
8.3.1 Asia-Pacific Pet Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pet Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pet Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Pet Therapeutics Market Size by Region
8.4.1 Asia-Pacific Pet Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pet Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pet Therapeutics Market Size (2017-2028)
9.2 Latin America Pet Therapeutics Market Size by Type
9.2.1 Latin America Pet Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Pet Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Pet Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Pet Therapeutics Market Size by Application
9.3.1 Latin America Pet Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Pet Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Pet Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Pet Therapeutics Market Size by Country
9.4.1 Latin America Pet Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Pet Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Pet Therapeutics Market Size by Type
10.2.1 Middle East & Africa Pet Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pet Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pet Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Pet Therapeutics Market Size by Application
10.3.1 Middle East & Africa Pet Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pet Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pet Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Pet Therapeutics Market Size by Country
10.4.1 Middle East & Africa Pet Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pet Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Therapeutics Introduction
11.1.4 Elanco Revenue in Pet Therapeutics Business (2017-2022)
11.1.5 Elanco Recent Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2017-2022)
11.2.5 Boehringer Ingelheim GmbH Recent Developments
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Therapeutics Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Therapeutics Business (2017-2022)
11.3.5 Ceva Sante Animale Recent Developments
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Company Details
11.4.2 Dechra Pharmaceuticals Business Overview
11.4.3 Dechra Pharmaceuticals Pet Therapeutics Introduction
11.4.4 Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2017-2022)
11.4.5 Dechra Pharmaceuticals Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Pet Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Pet Therapeutics Business (2017-2022)
11.5.5 Eli Lilly and Company Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Pet Therapeutics Introduction
11.6.4 Merck Revenue in Pet Therapeutics Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Vetoquinol
11.7.1 Vetoquinol Company Details
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Pet Therapeutics Introduction
11.7.4 Vetoquinol Revenue in Pet Therapeutics Business (2017-2022)
11.7.5 Vetoquinol Recent Developments
11.8 Zoetis
11.8.1 Zoetis Company Details
11.8.2 Zoetis Business Overview
11.8.3 Zoetis Pet Therapeutics Introduction
11.8.4 Zoetis Revenue in Pet Therapeutics Business (2017-2022)
11.8.5 Zoetis Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Pet Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Infectious Diseases
Table 3. Key Players of Dermatological Diseases
Table 4. Key Players of Orthopedic Diseases
Table 5. Key Players of Behavioral Disorders
Table 6. Key Players of Others
Table 7. Global Pet Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Pet Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Pet Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Pet Therapeutics Market Share by Region (2017-2022)
Table 11. Global Pet Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Pet Therapeutics Market Share by Region (2023-2028)
Table 13. Pet Therapeutics Market Trends
Table 14. Pet Therapeutics Market Drivers
Table 15. Pet Therapeutics Market Challenges
Table 16. Pet Therapeutics Market Restraints
Table 17. Global Pet Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Pet Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Pet Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2021)
Table 20. Ranking of Global Top Pet Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Pet Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pet Therapeutics Product Solution and Service
Table 24. Date of Enter into Pet Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Pet Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Pet Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Pet Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Pet Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Pet Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Pet Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Pet Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Pet Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Pet Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Pet Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pet Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pet Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Pet Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Pet Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Pet Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Pet Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pet Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pet Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Elanco Company Details
Table 65. Elanco Business Overview
Table 66. Elanco Pet Therapeutics Product
Table 67. Elanco Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 68. Elanco Recent Developments
Table 69. Boehringer Ingelheim GmbH Company Details
Table 70. Boehringer Ingelheim GmbH Business Overview
Table 71. Boehringer Ingelheim GmbH Pet Therapeutics Product
Table 72. Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Boehringer Ingelheim GmbH Recent Developments
Table 74. Ceva Sante Animale Company Details
Table 75. Ceva Sante Animale Business Overview
Table 76. Ceva Sante Animale Pet Therapeutics Product
Table 77. Ceva Sante Animale Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Ceva Sante Animale Recent Developments
Table 79. Dechra Pharmaceuticals Company Details
Table 80. Dechra Pharmaceuticals Business Overview
Table 81. Dechra Pharmaceuticals Pet Therapeutics Product
Table 82. Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Dechra Pharmaceuticals Recent Developments
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Pet Therapeutics Product
Table 87. Eli Lilly and Company Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Eli Lilly and Company Recent Developments
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Pet Therapeutics Product
Table 92. Merck Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Merck Recent Developments
Table 94. Vetoquinol Company Details
Table 95. Vetoquinol Business Overview
Table 96. Vetoquinol Pet Therapeutics Product
Table 97. Vetoquinol Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Vetoquinol Recent Developments
Table 99. Zoetis Company Details
Table 100. Zoetis Business Overview
Table 101. Zoetis Pet Therapeutics Product
Table 102. Zoetis Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Zoetis Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Infectious Diseases Features
Figure 3. Dermatological Diseases Features
Figure 4. Orthopedic Diseases Features
Figure 5. Behavioral Disorders Features
Figure 6. Others Features
Figure 7. Global Pet Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Dogs Case Studies
Figure 9. Cats Case Studies
Figure 10. Other Case Studies
Figure 11. Pet Therapeutics Report Years Considered
Figure 12. Global Pet Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Pet Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Pet Therapeutics Market Share by Region: 2021 VS 2028
Figure 15. Global Pet Therapeutics Market Share by Players in 2021
Figure 16. Global Top Pet Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Pet Therapeutics Revenue in 2021
Figure 18. North America Pet Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Pet Therapeutics Market Size Market Share by Type (2017-2028)
Figure 20. North America Pet Therapeutics Market Size Market Share by Application (2017-2028)
Figure 21. North America Pet Therapeutics Market Size Share by Country (2017-2028)
Figure 22. United States Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Pet Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Pet Therapeutics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Pet Therapeutics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Pet Therapeutics Market Size Share by Country (2017-2028)
Figure 28. Germany Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Pet Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Pet Therapeutics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Pet Therapeutics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Pet Therapeutics Market Size Share by Region (2017-2028)
Figure 38. China Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Pet Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Pet Therapeutics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Pet Therapeutics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Pet Therapeutics Market Size Share by Country (2017-2028)
Figure 48. Mexico Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Pet Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Pet Therapeutics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Pet Therapeutics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Pet Therapeutics Market Size Share by Country (2017-2028)
Figure 54. Turkey Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Elanco Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 58. Boehringer Ingelheim GmbH Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 59. Ceva Sante Animale Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 60. Dechra Pharmaceuticals Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 62. Merck Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 63. Vetoquinol Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 64. Zoetis Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


★調査レポート[ペット治療の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10464)販売に関する免責事項を必ずご確認ください。
★調査レポート[ペット治療の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • タンパク質＆ペプチド治療薬の世界市場インサイト・予測（～2028年）
  • 脳卒中治療の世界市場インサイト・予測（～2028年）
  • アンチセンスオリゴヌクレオチド（ASO）治療薬の世界市場インサイト・予測（～2028年）
  • 神経変性疾患治療薬の世界市場インサイト・予測（～2028年）
  • 閉経後膣萎縮治療薬の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆